FDA Gives Thumbs Up To Multiple Sclerosis Drug From Novartis The Food and Drug Administration approved a Novartis drug that can help patients with relapsing forms of multiple sclerosis. Mayzent (siponimod) showed benefits in delaying the progression of disability and cognitive decline. by Milafel Dacanay